News
Click below to explore Ossiform’s recent press releases and news
Jackie Fielding joins Ossiform® Board of Directors
Ossiform Ltd. & Ossiform ApS
85 Great Portland Street, London, England, W1W 7LT
Oslogade 1, 5000 Odense,...
Ossiform® obtains ISO 13485 certification
(September 26, Odense): Ossiform® is pleased to announce that it has obtained the ISO 13485 certification thro...
CELLINK and Ossiform® Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform®’s P3D Bone material
A printable bioink based on Ossiform®’s P3D Bone material
CELLINK and Ossiform® look to capitalize on synerg...
Ossiform® raises new capital
Ossiform® raises capital through West Hill
ODENSE, October 5th, 2022 – Ossiform®, We Print Bone™, is pleased ...
CAM Bioceramics and Ossiform® team up for OMTEC 2022
Ossiform® will be participating at the Orthopedic Manufacturing & Technology Exposition and Conference 202...
Ossiform® – Announces rebrand
Ossiform® - Announces rebrand
ODENSE, January 5th, 2022 - Ossiform®, We Print Bone™, is pleased to announce...
Patent for Ossiform®’s technology granted in China
Chinese Patent Granted for Ossiform®’s 3D printing technology
August 10th 2021, the China National Intellectu...
Ossiform® – New Chairman of the Board
Ossiform® – New market-oriented Chairman of the Board
ODENSE, 1st June 2021 – Ossiform®, We Print Bone™, is p...
Treating mouse skull defects with tricalcium phosphate implants
The performance of 3D printed bone implants in a mouse model of craniectomy
The performance of P3D Bone as a ...
Patent for Ossiform®’s technology granted in the USA
U.S. Patent Granted
June 9th 2020, the United States Patent and Trademark office (USPTO) announced that Ossif...
Ossiform® raises capital through West Hill
Capital rise through West Hill Capital
ODENSE, May 18th, 2020 – Ossiform®, We Print Bone™, is pleased to anno...
Ossiform® enters U.S. partnership with Asimov Ventures
First step into the U.S. market
Ossiform® receives investment from New York based venture capital firm, Asimo...